Is Recommending 0.01% Atropine for Myopia Control Clinically Meaningful?

被引：2
|
作者：
Khanal, Safal [1 ]
Phillips, John R. [2 ,3 ]
机构：
[1] Univ Alabama Birmingham, Dept Optometry & Vis Sci, Birmingham, AL USA
[2] Univ Auckland, Sch Optometry & Vis Sci, Auckland, New Zealand
[3] Univ Auckland, Sch Optometry & Vis Sci, 85 Pk Rd, Auckland 1023, New Zealand
来源：
JAMA OPHTHALMOLOGY | 2024年 / 142卷 / 03期
关键词：
D O I：
10.1001/jamaophthalmol.2023.6771
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Topical Atropine in the Control of Myopia
    Tan, Donald
    Tay, Su Ann
    Loh, Kai-Lyn
    Chia, Audrey
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2016, 5 (06): : 424 - 428
  • [32] Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01%
    Rose, Loreto V. T.
    Schulz, Angela M.
    Graham, Stuart L.
    PLOS ONE, 2021, 16 (07):
  • [33] Efficacy of 0.01% low dose atropine and its correlation with various factors in myopia control in the Indian population
    Shweta Chaurasia
    Seema Negi
    Ashok Kumar
    Srishti Raj
    Sushmita Kaushik
    Rahul Khanna M. Optom
    Pranav Kishore
    Mangat Ram Dogra
    Scientific Reports, 12
  • [34] A Review of Myopia Control with Atropine
    Tran, Huy D. M.
    Tran, Yen H.
    Tran, Tuan D.
    Jong, Monica
    Coroneo, Minas
    Sankaridurg, Padmaja
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (05) : 374 - 379
  • [35] Efficacy of 0.01% low dose atropine and its correlation with various factors in myopia control in the Indian population
    Chaurasia, Shweta
    Negi, Seema
    Kumar, Ashok
    Raj, Srishti
    Kaushik, Sushmita
    Optom, Rahul Khanna M.
    Kishore, Pranav
    Dogra, Mangat Ram
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [36] IS TREATMENT WITH ATROPINE 0.01% EYEDROPS SAFE TO PREVENT THE PROGRESSION OF CHILDHOOD MYOPIA?
    Manuel Siurana, Jose
    Akel, Georges
    Cavero, Lluis
    Mones, Anna
    Anabalon, Ezequiel
    Sol Ventura, Paula
    ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 : A80 - A80
  • [37] Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns
    Erdinest, Nir
    London, Naomi
    Levinger, Nadav
    Lavy, Itay
    Pras, Eran
    Morad, Yair
    CONTACT LENS & ANTERIOR EYE, 2022, 45 (04):
  • [38] Choroidal Changes During and After Discontinuing Long-Term 0.01% Atropine Treatment for Myopia Control
    Lee, Samantha Sze-Yee
    Lingham, Gareth
    Clark, Antony
    Read, Scott A.
    Alonso-Caneiro, David
    Mackey, David A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (10)
  • [39] Longitudinal changes of macular choroidal thickness in response to 0.01% atropine eye drop for myopia control in children
    Kobia-Acquah, Emmanuel
    Flitcroft, Daniel
    Lingham, Gareth
    Loughman, James
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [40] Atropine 0.01% Eye Drops for Myopia Control in American Children: A Multiethnic Sample Across Three US Sites
    G. Luke Larkin
    Alifiya Tahir
    K. David Epley
    Cynthia L. Beauchamp
    John T. Tong
    Robert A. Clark
    Ophthalmology and Therapy, 2019, 8 : 589 - 598
12345